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Over the past 50 years, marine invertebrates, especially sponges, have proven to be a valuable 
source of new and/or bioactive natural products that have the potential to be further developed 
as lead compounds for pharmaceutical applications. Although marine benthic invertebrate 
communities occurring off the coast of South Africa have been explored for their biomedicinal 
potential, the natural product investigation of marine sponges from the sub-Antarctic Islands 
in the Southern Ocean for the presence of bioactive secondary metabolites has been relatively 
unexplored thus far. We report here the results for the biological screening of both aqueous 
and organic extracts prepared from nine specimens of eight species of marine sponges, 
collected from around Marion Island and the Prince Edward Islands in the Southern Ocean, 
for their cytotoxic activity against three cancer cell lines. The results obtained through this 
multidisciplinary collaborative research effort by exclusively South African institutions has 
provided an exciting opportunity to discover cytotoxic compounds from sub-Antarctic sponges, 
whilst contributing to our understanding of the biodiversity and geographic distributions of 
these cold-water invertebrates. Therefore, we acknowledge here the various contributions of 
the diverse scientific disciplines that played a pivotal role in providing the necessary platform 
for the future natural products chemistry investigation of these marine sponges from the sub-
Antarctic Islands and the Southern Ocean.
Significance:
• This study will contribute to understanding the biodiversity and geographic distributions of
sponges in the Southern Ocean.
• This multidisciplinary project has enabled the investigation of marine sponges for the presence 
of cytotoxic compounds.
• Further investigation will lead to the isolation and identification of cytotoxic compounds
present in the active sponge extracts.
Introduction
Marine biodiscovery is the search for marine natural products with potential economic and societal 
benefits for use as agrochemicals, cosmetics, anti-fouling agents, nutraceuticals and pharmaceuticals.1,2 
Generally, marine invertebrates utilise their secondary metabolites or natural products as a form of 
chemical defence against predators and as a competitive advantage in their perpetual battle for limited 
resources, such as nutrients and space.2,3 Over the past 50 years, marine invertebrates and their 
associated microorganisms have proved to be an important source of bioactive natural products for 
the development of new pharmaceuticals,4,5 especially anti-cancer agents, e.g. Adcetris®, Halaven® 
and Yondelis®, that were discovered by initially screening for cytotoxic compounds against cancer 
cell lines.6,7 Marine sponges (Phylum: Porifera) have arguably been one of the dominant sources of 
marine natural products that are utilised commercially for their beneficial pharmacological properties in 
biomedical research.6 There currently are seven FDA-approved marine natural products derived drugs, 
of which four are anti-cancer chemotherapeutic agents, and a further 13 marine-derived agents that are 
either in human clinical trials or in advanced pre-clinical status, including a synthetic derivative of the 
South African marine sponge natural product Hemiasterlin.6,7 The latest review by Newman and Cragg8 
highlights the significant contribution of natural products research to the field of drug discovery, with an 
estimated 77% of all anti-cancer drugs approved between 1940 and 2014 being small molecule natural 
products and natural product-derived compounds.
Southern Africa’s marine biota is home to a wealth of biodiversity along the approximately 3000-km 
coastline of South Africa and around the archipelagos of the Southern Ocean, including the Prince 
Edward Islands (PEIs) which consist of Marion Island and Prince Edward Island. The biomedicinal 
potential of southern African marine invertebrates was initially revealed through the marine biodiscovery 
efforts of Robert Pettit (Arizona State University) and Yoel Kashman (Tel Aviv University).9,10 The initial 
biological screening for cytotoxic compounds and subsequent natural products chemistry work by 
Pettit and his co-workers on their South African marine collections resulted in the isolation of two 
very important classes of bioactive compounds known as the cephalostatins and spongiostatins.9,10 
The cephalostatins and spongiostatins were isolated through cytotoxic activity-directed purification of 
crude extracts and are well known to be some of the most cytotoxic secondary metabolites (about 
1 nM activity) ever to be screened by the United States National Cancer Institute (NCI) against their 60 
cancer cell line panel (NCI-60).9,10 Cephalostatin 1 and its closely related naturally occurring analogues 
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were isolated from aqueous and organic extracts of the South African 
marine tube worm Cephalodiscus gilchristi, while Spongiostatins 4 
and 5 were isolated from the organic extract of the bright orange ‘wall-
sponge’ Trachycladus spinispirulifer collected off the southern coasts of 
South Africa.9,10 The collaborative biodiscovery programme in Sodwana 
Bay between Kashman, the Oceanography Research Institute and the 
pharmaceutical company PharmaMar involved the primary biological 
screening of crude extracts for cytotoxic compounds against the P-388, 
A549, HT-29 and MEL-28 cancer cell lines. This screening resulted in 
the discovery of 33 new bioactive natural product compounds, mostly 
isolated from marine sponges, of which 9 compounds were patented for 
their anti-cancer properties.9,10 These compounds include two cytotoxic 
peptides – Hemiasterlin and Geodiamolide TA – isolated from the marine 
sponge Hemiasterella minor (Kirkpatrick); a synthetic analogue of 
Hemiasterlin was subsequently developed and has successfully entered 
phase one of human clinical trials as an anti-cancer drug.6,9 
Between 1992 and 2012, the marine natural products research groups at 
Rhodes University, in collaboration with various other scientific research 
groups and institutes, led the search for, and provided important 
contributions to, the discovery of novel bioactive natural product comp-
ounds from southern African marine organisms.9-12 Davies-Coleman 
and colleagues13,14 have previously reported the screening of several 
extracts of southern African marine invertebrates for anti-oeso phageal 
cancer activity, including five deep-water sponges collected from the 
PEIs that were tested against the WHCO1 cell line. The sponges were 
collected during the 2004 annual relief voyage by the SA Agulhas I.13 To 
the best of our knowledge, this report was the first and only report of 
a multidisciplinary research consortium from exclusively South African 
institutions (Rhodes University, University of Cape Town and Council 
for Scientific and Industrial Research), searching for cytotoxic chemical 
compounds from marine sponges with potential anti-tumour properties 
from the Southern Ocean.13 The natural product investigation by Davies-
Coleman et al.13 of the most promising extract was unfortunately 
hampered by the paucity of the sponge material collected (ca. 200 g), 
although the amount of crude organic extract derived was not given. As 
far as we know, a subsequent collection in 2005 has to date not yielded 
any new and/or bioactive marine natural product compounds. 
The relatively unexplored natural product diversity and pharmaceutical 
potential of marine invertebrates from the sub-Antarctic Islands and 
Southern Ocean, therefore presents us with an exciting opportunity 
and we have thus initiated a new multidisciplinary effort by a concerted 
group of South African institutions to explore the cytotoxic potential of 
marine sponges from the sub-Antarctic Islands and the Southern Ocean. 
We report here the cytotoxic activity, against three different cancer cell 
lines, of both aqueous and organic crude extracts prepared from nine 
sponge specimens, collected from various depths around the PEIs in the 
Southern Ocean. 
Materials and methods
Researchers from the University of Cape Town, Rhodes University, the 
Council for Scientific and Industrial Research, the South African Environ-
mental Observation Network and the Department of Environmental 
Affairs participated in the annual relief voyage to the PEIs on board the 
research vessel SA Agulhas II from 6 April to 16 May 2015. As part of 
the inter-island biodiversity survey between Prince Edward and Marion 
Islands (46.77°S, 37.85°E), benthic trawls were performed using a steel 
dredge (1.0 m × 0.3 m ×1.0 m) at various depths (60–254 m) along 
four pre-determined stations (Figure 1). At each station, the dredge was 
towed behind the vessel at 0.5 knots for approximately 15–20 min. 
From the various benthic dredges, nine sponge specimens were 
collected, labelled and photographed and the relevant collection infor-
mation, e.g. GPS coordinates and depths, was recorded. The sponge 
specimens were placed in sealed bags, immediately frozen on board 
the research vessel until the end of the journey and transferred after the 
expedition to a freezer in the Department of Chemistry at the University of 
Cape Town. Histological and genetic samples (~5–10 cm3) were taken 
from each specimen for identification and stored in 96% (v/v) ethanol. 
Vouchers of the sponges are housed in the collection of Dr Toufiek 
Samaai (Department of Environmental Affairs). 
Figure 1: Survey area around the Prince Edward Islands, indicating the 
position of the four benthic dredge stations: (1) Prince 
Edward Island (PEI); (2 and 3) between the islands; and (4) 
south of Marion Island. Station depths are: 130 m (1), 65 m 
(2), 230 m (3) and 254 m (4). 
All sponge specimens were processed individually in the same manner. A 
frozen portion (up to 90% of the wet mass) of each sponge was cut into 
small pieces, frozen in liquid nitrogen and lyophilised until the material 
was dry. The mass of the dried sponges was recorded and the sponge 
materials were then subjected to solvent extraction. Both aqueous 
(100% deionised water) and organic (50:50 mixture of methanol and 
dichloromethane) crude extracts of the sponges were prepared by 
following, where possible, the protocol for marine specimens established 
by scientists at the Developmental Therapeutics Program of the NCI.15
The resulting 18 crude extracts, one organic (suffix ‘-1’) and one aqueous 
(suffix ‘-2’) for each sponge, were screened for their cytotoxic activity 
against the cervical (HeLa ATCC CCL-2), lung (A549 ATCC CCL-185) 
and breast (MCF7 ATCC HTB-22) cancer cell lines. Cells were cultured in 
Dulbecco’s Modified Eagle’s Medium supplemented with 10% (v/v) foetal 
bovine serum, 2 mM Glutamax and 100 U/mL penicillin/streptomycin/
amphotericin at 37 °C with 9% CO2. Sub-culturing was carried out by 
removing the media, washing with phosphate-buffered saline (10 mM 
Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 140 mM NaCl, pH 7.4) and lifting 
the cells using a 1% (v/v) trypsin in 0.3% (w/v) ethylenediaminetetraacetic 
acid (EDTA) solution. Cells were confirmed to be mycoplasma free by 
microscopy after staining with Hoechst 33342. The chemosensitivity of 
the cell lines to the extracts was tested using the WST-1 assay. For each 
extract, 5 x 103 cells/well were seeded in a 96-well plate and allowed to sit 
overnight before being treated in triplicate with the extracts at a range of 
concentrations (0.1–100 µg/mL). The plates were incubated at 37 °C and 
9% CO2 for 72 h. All the media were removed and 100 µL WST-1 reagent 
(0.5 mg/mL) was added to each well after the 72-h incubation. The plates 
were incubated at 37 °C in 9% CO2 and the absorbance at 450 nm read 
after 2 h, 4 h and 6 h. For all treatments the half maximum effective 
concentration (EC50) for data from the reading at 6 h was calculated by 
non-linear regression using GraphPad Prism version 4.0. Spectroscopic 
analyses of portions of the crude extracts were acquired using standard 
pulse sequences on a Bruker 600-MHz nuclear magnetic resonance 
(NMR) spectrometer, equipped with a 5-mm Prodigy cryoprobe. 
Results
Taxonomic identification of the nine sponge specimens collected revealed 
eight sponge species (Table 1) as two sponge specimens (MAR15-005 
and MAR15-012), collected from two distant geographical locations 
(Dredge Stations 3 and 1, respectively; Figure 1), were identified as 
the same Halichondria (Halichondria) cf. panicea sponge species. The 
preliminary biological screening results obtained for the crude extracts 
are summarised in Table 1 and indicate that only three (MAR15-001, 
MAR15-005, MAR15-012) of the nine sponge specimens exhibited 
cytotoxicity against the cancer cell lines tested. 
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The aqueous extract of the sponge Myxilla (Ectyomyxilla) kerguelensis 
(MAR15-001-2) displayed cytotoxic activity (EC50 11.7 µg/mL) against 
the HeLa cervical cancer cell line (Table 1). The organic extracts of the 
two sponges H. (H.) cf. panicea were similarly cytotoxic (MAR15-005-1; 
EC50 33.4 µg/mL and MAR15-012-1; EC50 35.2 µg/mL) against the 
A549 lung cancer cell line (Table 1). Interestingly, the aqueous extract 
of H. (H.) cf. panicea (MAR15-012-2) was similarly cytotoxic (EC50 
~16 µg/mL) to both the cervical (HeLa) and breast cancer (MCF7) 
cell lines, whilst the aqueous extract of the other H. (H.) cf. panicea 
specimen (MAR15-005-2) did not show any cytotoxic activity (Table 1) 
against any of the cancer cell lines. It is also interesting to note that a 
number of the samples, particularly the organic extracts, induced dose-
dependent proliferation in the MCF7 and A549 cell lines (shown by P in 
Table 1).
Proton (1H) NMR spectra (Figure 2) were acquired for both organic 
and aqueous extracts of the two different sponge specimens H. (H.) 
cf. panicea to examine their secondary metabolite profile and assist us 
in the interpretation of the bioactivity results obtained. A comparative 
analysis of the 1H NMR spectra of the organic extracts for H. (H.) 
cf. panicea (MAR15-005-1 and MAR15-012-1) indicated a high degree 
of consistency in their spectroscopic profile (Figure 2a). A cursory 
examination of the 1H NMR spectra recorded for the MAR15-005-2 and 
MAR15-012-2 aqueous extracts revealed some degree of variation in 
their secondary metabolite spectroscopic profile (Figure 2b). 
Table 1: Taxonomy, dredge details and EC50 (± sem; µg/mL) values against HeLa, MCF7 and A549 cancer cell lines for nine species of sponges collected 
from the Marion Island region
EC50 (μg/mL)











MAR15-001-2 11.7 (±1.1) P –
Halichondria (H) cf. panicea
MAR15-005-1
3 230
– P 33.4 (±1.3)

























MAR15-011-2 – P –
Halichondria (H) cf. panicea
MAR15-012-1
1 130
– P 35.2 (±4.4)





MAR15-013-2 – P P
Note: For each sponge specimen, suffix ‘-1’ = organic extract and suffix ‘-2’ = aqueous extract. 
*P, proliferation 
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Conclusion
The results obtained from the biological screening of the nine sponge 
specimens (eight species) collected off the PEIs are exceptionally 
encouraging as the potential presence of cytotoxic secondary metabolites 
of three sponge specimens has been revealed. The similar cytotoxicity 
(EC50 ~34 µg/mL; Table 1) of the organic sponge extracts MAR15-005-1 
and MAR15-012-1 (collected at two different locations; Figure 1) against 
the A549 lung cancer cell line, coupled with their significantly congruent 
1H NMR profile (Figure 2a), is very interesting as it suggests the possible 
presence of the same active molecule(s) from allopatric specimens of H. 
(H.) cf. panicea, that is, different specimens of the same species from 
different locations. However, the aqueous extracts prepared from the 
same two H. (H.) cf. panicea sponge specimens exhibit different cytotoxic 
(Table 1) and spectroscopic profiles (Figure 2b), suggesting possible 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5









Figure 2: Comparison of the secondary metabolite profile of the two different specimens of Halichondria (Halichondria) cf. panicea. Stacked proton nuclear 
magnetic resonance spectra (δH 0.5–9.0 ppm) of (a) organic extracts (MAR15-005-1 and MAR-012-1) and (b) aqueous extracts (MAR15-005-2 
and MAR-012-2).
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different polar secondary metabolite constituents in these extracts. This 
variation in the biological activity and secondary metabolite profile of 
different specimens of the same sponge species was also observed in 
three different H. (H.) cf. panicea specimens by Davies-Coleman and co-
workers, which can be attributed to the production of different secondary 
metabolites as a result of different environmental pressures such as 
predation and competition with neighbouring species.13 
Marine sponges belonging to the genus Halichondria are known as 
producers of a wide range of bioactive secondary metabolites, including 
the well-known polyether macrolide class of highly cytotoxic compounds, 
such as the marine natural product Halichondrin B that showed excellent 
initial cancer cell toxicity and subsequently led to the development of the 
approved anti-cancer drug Halaven®.6,7 Therefore, in our future work, we 
will aim to isolate and identify the cytotoxic compounds present in the 
two specimens of H. (H.) cf. panicea, as they could potentially be useful 
for further chemical and biological studies. The aqueous extract of the 
sponge Myxilla (Ectyomyxilla) kerguelensis (MAR15-001-2) displayed 
cytotoxic activity (EC50 11.7 µg/mL; Table 1) against the HeLa cervical 
cancer cell line. A literature search revealed that the Marion Island sponge 
Myxilla (Ectyomyxilla) kerguelensis has not been extensively studied for its 
natural products chemistry composition and therefore presents us with a 
unique opportunity to address this knowledge gap. We have also recently 
extended our primary biological screening of these sponge extracts to 
include antiplasmodial and anti-tubercular bioassays, in which none of 
the extracts exhibited any activity. The results obtained in this study will 
now guide the purification, isolation and characterisation of the bioactive 
molecules responsible for the observed cytotoxicity against our panel of 
three cancer cell lines. Additionally, to supplement the paucity in biomass 
for the sponges collected during the 2015 expedition, more samples were 
collected from the same location on the recent 2016 survey to Marion 
Island and will be investigated in the same manner. 
We highlight and acknowledge the various contributions from diverse 
scientific disciplines that have played a pivotal role in providing the 
necessary platform to enable this newly established marine biodiscovery 
effort to explore the natural products chemistry and biomedicinal value 
of marine sponges from the PEIs and Southern Ocean. We hope that our 
future collections of sponges and other marine invertebrates from the 
Southern Ocean will lead to the isolation and identification of highly potent 
cytotoxic marine natural product compounds such as Halichondrin B6,7, 
Cephalostatin 1 and Spongiostatin 49,10, which have the potential to 
be further developed into anti-cancer agents. In our endeavour, we 
also hope to contribute to the understanding of the biodiversity and 
geographic distributions of these cold-water invertebrates.
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